...
首页> 外文期刊>The American Journal of Cardiology >Meta-analysis of randomized studies comparing intravascular ultrasound versus angiographic guidance of percutaneous coronary intervention in pre-drug-eluting stent era.
【24h】

Meta-analysis of randomized studies comparing intravascular ultrasound versus angiographic guidance of percutaneous coronary intervention in pre-drug-eluting stent era.

机译:在药物洗脱支架时代,比较经皮冠状动脉介入治疗的血管内超声与血管造影指导的随机研究的荟萃分析。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

We conducted a formal meta-analysis of peer-reviewed, published, randomized studies comparing intravascular ultrasound (IVUS)-guidance and angiographic-guided bare metal stent implantation. A total of 8 studies were identified. Because the Balloon Equivalent to Stent (BEST) study was a noninferiority trial designed to compare 2 very different percutaneous coronary intervention strategies-IVUS-guided aggressive balloon angioplasty (with bail-out stenting) and angiographic-guided deliberate bare metal stent implantation-it was eliminated. An unadjusted random-effects meta-analysis was used to compare the IVUS-guided and non-IVUS-guided stenting in the 7 remaining studies. A total of 2,193 patients were randomized in 5 multicenter and 2 single-center studies. IVUS guidance was associated with a significantly larger postprocedure angiographic minimum lumen diameter. The mean difference was 0.12 mm (95% confidence interval [CI] 0.06 to 0.18, p <0.0001). IVUS guidance was also associated with a significantly lower rate of 6-month angiographic restenosis (22% vs 29%, odds ratio 0.64, 95% CI 0.42 to 0.96, p = 0.02), a significant reduction in the revascularization rate (13% vs 18%, odds ratio 0.66, 95% CI 0.48 to 0.91, p = 0.004), and overall major adverse cardiac events (19% vs. 23%, odds ratio 0.69, 95% CI 0.49 to 0.97, p = 0.03). However, no significant effect was seen for myocardial infarction (p = 0.51) or mortality (p = 0.18). In conclusion, IVUS guidance for bare metal stent implantation improved the acute procedural results (angiographic minimum lumen diameter) and thereby reduced angiographic restenosis and repeat revascularization and major adverse cardiac events, with a neutral effect on death and myocardial infarction during a follow-up period of 6 months to 2.5 years.
机译:我们对同行评审,已发表的随机研究进行了正式的荟萃分析,比较了血管内超声(IVUS)指导和血管造影术引导的裸金属支架植入术。总共确定了8个研究。因为球囊等效支架(BEST)研究是一项非劣效性试验,旨在比较2种非常不同的经皮冠状动脉介入治疗策略-IVUS引导的积极性球囊血管成形术(采用救助支架)和血管造影术引导的故意裸金属支架植入术-被淘汰。在其余7项研究中,使用未经调整的随机效应荟萃分析比较了IVUS引导和非IVUS引导的支架。在5项多中心研究和2项单中心研究中,共有2193名患者被随机分组​​。 IVUS指导与术后更大的血管造影最小管腔直径有关。平均差异为0.12毫米(95%置信区间[CI] 0.06至0.18,p <0.0001)。 IVUS指导还与6个月血管造影再狭窄发生率显着降低有关(22%vs 29%,优势比0.64,95%CI 0.42至0.96,p = 0.02),血运重建率显着降低(13%vs 18%,优势比0.66,95%CI 0.48至0.91,p = 0.004)和总体主要不良心脏事件(19%vs. 23%,优势比0.69,95%CI 0.49至0.97,p = 0.03)。但是,对于心肌梗塞(p = 0.51)或死亡率(p = 0.18)均未见明显影响。总之,IVUS裸金属支架植入的指南改善了急性手术结果(血管造影术的最小管腔直径),从而减少了血管造影术的再狭窄,重复血运重建和主要的不良心脏事件,对随访期间的死亡和心肌梗塞具有中性作用6个月至2。5年。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号